Previous
Previous

33. Primary Human Tissue Models for Metabolic Dysfunction-Associated Liver Disease - toward Streamlining Drug Discovery with Patient-Derived Assays

Next
Next

31. Modulation of OGG1 enzymatic activity by the cellular machinery – have all the boxes been ticked?